Profilo
Ying Min Wang is currently Director, Digital Health & MedTech at Clavystbio Pte Ltd. since 2022.
Dr. Wang is also Director at Sunbird Bio, Inc. since 2023.
Dr. Wang completed undergraduate studies at Duke University and earned a doctorate from the California Institute of Technology.
Posizioni attive di Ying Min Wang
| Società | Posizione | Inizio |
|---|---|---|
Clavystbio Pte Ltd.
Clavystbio Pte Ltd. Investment ManagersFinance Clavystbio invests in companies located across the globe. The firm focuses on biotech, medtech, real estate, service platforms and digital health sectors. It provides financing in early-stage capital requirements. | Investitore di Private Equity | 01/01/2022 |
Sunbird Bio, Inc.
Sunbird Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company developing protein-based technologies to improve diagnosis and treatment of neurological disorders & cancer | Direttore/Membro del Consiglio | 01/05/2023 |
Formazione di Ying Min Wang
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clavystbio Pte Ltd.
Clavystbio Pte Ltd. Investment ManagersFinance Clavystbio invests in companies located across the globe. The firm focuses on biotech, medtech, real estate, service platforms and digital health sectors. It provides financing in early-stage capital requirements. | Finance |
Sunbird Bio, Inc.
Sunbird Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company developing protein-based technologies to improve diagnosis and treatment of neurological disorders & cancer | Health Technology |
















